NAUT Stock Analysis: Buy, Sell, or Hold?
NAUT - Nautilus Biotechnolgy, Inc. Common Stock
$0.89
-0.02 (-2.04%)
▼
5d:
-7.21%
30d:
-14.01%
90d:
-67.68%
HOLD
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Jul 28, 2026
0d
Get Alerted When NAUT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NAUT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NAUT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NAUT is currently trading at $0.89, which is considered slightly low relative to its 30-day fair value range of $0.78 to $1.42.
Technical Outlook: Technically, NAUT is in a strong downtrend. Immediate support is located at $0.84, while resistance sits at $0.98.
Market Sentiment: NAUT scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+351.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NAUT is in a strong downtrend. Immediate support is located at $0.84, while resistance sits at $0.98.
Market Sentiment: NAUT scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+351.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.78 -
$1.42
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Protect Your Profits
Holding NAUT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (61/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 351.6% below Wall St target ($4.00)
- CAUTION: Bottoming setup, but lagging the sector by 12% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-7.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.78 -
$1.42
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.84
Resistance Level
$0.98
Current Trend
Strong Downtrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.70
Wall Street Target
$4.00
(+351.6%)
Share & Embed Analysis
Last updated: August 29, 2026 9:39 AM ET
Data refreshes hourly during market hours. Next update: 10:39 AM
Data refreshes hourly during market hours. Next update: 10:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NAUT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Sujal M Patel
BUY
25000 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 38 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 46 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 53 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$34 | 49 HOLD |
Advanced NAUT Option Strategies
Professional options setups generated by AI based on today's NAUT price and gamma walls.
